cancerspЮжно-Российский онкологический журнал/ South Russian Journal of CancerSouth Russian Journal of Cancer2686-9039АНО "Перспективы онкологии"10.37748/2687-0533-2020-1-1-6cancersp-42Research ArticleКлинические наблюденияCLINICAL CASE REPORTSЛЕЧЕНИЕ ЛОКАЛИЗОВАННОГО РАКА ПОЧКИTREATMENT OF LOCALIZED RENAL CANCERhttps://orcid.org/0000-0002-4468-3670КульченкоН. Г.KulchenkoN. G.

Кульченко Нина Геннадьевна — кандидат медицинских наук, врач-уролог, врач ультразвуковой диагностики, старший преподаватель кафедры гистологии, цитологии и эмбриологии Медицинского института

117198, , г. Москва, ул. Миклухо-Маклая, д. 6 

SPIN: 1899-7871  

Nina G. Kulchenko — Cand. Sci. (Med.), Urologist, Senior Lecturer, Department of Histology, Cytology and Embryology

6 Miklukho-Maklaja str., Moscow 117198

SPIN: 1899-7871   

kle-kni@mail.ruФГАОУ ВО «Российский университет дружбы народов»РоссияPeoples Friendship University of Russia (RUDN University)Russian Federation202007032020116975Copyright © Кульченко Н.Г., 20202020Кульченко Н.Г.Kulchenko N.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cancersp.com/jour/article/view/42

Почечно-клеточный рак (ПКР) часто встречается в 3,9% среди онкологических заболеваний. В России, в 2018 г. было зарегистрировано 24 291 новых случаев заболевания ПКР, а в США – 63 990. Наиболее распространенным подходом к лечению ПКР ранней стадии – это радикальная нефрэктомия, или резекция почки. В этой статье представлен клинический случай успешного хирургического лечения локализованного ПКР Т3 аN0M0 у мужчины 65 лет. Через 8 недель после резекции почки биохимические показатели крови и скорость клубочковойфильтрации достоверно не отличались от исходных значений (р > 0,05). При контрольной КТ брюшной полости и забрюшинного пространства (через 12 недель) увеличенных регионарных, парааортальных и параковальных лимфатических узлов не выявлено. Резекция почки является альтернативным хирургическим лечением локализованных форм ПКР, так как обеспечивает максимальную сохранность органа. Резекцию почки следует предпочитать нефрэктомии (когда это технически и стратегически возможно), поскольку данный вид вмешательства обеспечивает лучшее сохранение функции почек, не увеличивая риск послеоперационных осложнений.

Renal cell carcinoma (RCC) accounts for 3.9 % of all cancers. In 2018, 24,291 and 63,990 new cases of RCC were recorded in Russia and the US, respectively. The most common approach to early stage RCC treatment consists in either radical or partial nephrectomy. This article presents a clinical case of the successful treatment of a localized renal cell carcinoma T3аN0M0 in a 65-year-old man. 8 weeks after the performed kidney resection, the biochemical blood parameters and glomerular filtration rate did not significantly differ from the initial values (p > 0.05). A control CT examination of the abdominal cavity and the retroperitoneal space (after 12 weeks) detected no enlarged regional, paraaortic and paracanal lymph nodes. Partial nephrectomy is considered to be an alternative surgical treatment of localized RCC forms due to its potential for maximal organ preservation. Partial nephrectomy should be a method of choice in cases where it is technically and strategically feasible, since this type of surgical intervention provides for a better preservation of renal function under a lower risk of postoperative complications.

почечно-клеточный ракрезекция почкифункция почкикомпьютерная томография почкималоинвазивное хирургическое лечениескорость клубочковой фильтрацииrenal cell carcinomapartial nephrectomykidney functioncomputed tomographyminimally invasive surgeryglomerular filtration rateReferencesСафронова Е. Ю., Нюшко К. М., Алексеев Б. Я., Калпинский А. С., Поляков В. А., Каприн А. Д. Способы осуществления гемостаза при выполнении резекции почки. Исследования и практика в медицине. 2016;3(1):58–65 https://doi.org/10.17709/2409–2231–2016–3-1–8Safronova E.Yu., Nushko K. M., Alekseev B. Ya., Kalpinskiy A. S., Polyakov V. A., Kaprin A. D. Methods of performing of hemost asis during kidney resection. Research and Practical Medicine Journal. 2016;3(1):58–65 (In Russian). https://doi.org/10.17709/2409–2231–2016–3-1–8Kriegmair M. C., Bertolo R., Karakiewicz P. I., Leibovich B. C., Ljungberg B., Mir M. C., et al. Systematic Review of the Management of Local Kidney Cancer Relapse. Eur Urol Oncol. 2018;1(6):512–523. https://doi.org/10.1016/j.euo.2018.06.007Kriegmair M. C., Bertolo R., Karakiewicz P. I., Leibovich B. C., Ljungberg B., Mir M. C., et al. Systematic Review of the Management of Local Kidney Cancer Relapse. Eur Urol Oncol. 2018;1(6):512–523. https://doi.org/10.1016/j.euo.2018.06.007Minervini A., Campi R., Mari A., Antonelli A. Re: Renal Cancer Surgery for Patients Without Preexisting Chronic Kidney Disease: Is There a Survival Benefit for Partial Nephrectomy? European Urology. 2019 May;76(3):407–408. https://doi.org/10.1016/j.eururo.2019.05.021Minervini A., Campi R., Mari A., Antonelli A. Re: Renal Cancer Surgery for Patients Without Preexisting Chronic Kidney Disease: Is There a Survival Benefit for Partial Nephrectomy? European Urology. 2019 May;76(3):407–408. https://doi.org/10.1016/j.eururo.2019.05.021Алексеев Б. Я., Калпинский А. С., Тараки И. А., Мухомедьярова А. А., Нюшко К. М., Воробьев Н. В. и др. Возможности органосберегающего лечения больных с множественными опухолями почек. Исследования и практика в медицине. 2017;4(2):54–https://doi.org/10.17709/2409–2231–2017–4-2–7Alekseev B.Ya., Kalpinskiy A. S., Taraki I. A., Mukhomed’yarova A. A., Nyushko K. М., Vorobyev N. V., et al. Possibilities of organpreserving treatment of patients with multiple renal tumors. Research and Practical Medicine Journal. 2017;4(2):54–60 (In Russian). https://doi.org/10.17709/2409–2231–2017–4-2–7Porta C., Cosmai L., Leibovich B. C., Powles T., Gallieni M., Bex A. The adjuvant treatment of kidney cancer: a multidisciplinary outlook. Nat Rev Nephrol. 2019 Jul;15(7):423–433. https://doi.org/10.1038/s41581–019–0131-xPorta C., Cosmai L., Leibovich B. C., Powles T., Gallieni M., Bex A. The adjuvant treatment of kidney cancer: a multidisciplinary outlook. Nat Rev Nephrol. 2019 Jul;15(7):423–433. https://doi.org/10.1038/s41581–019–0131-xLam J. S., Leppert J. T., Figlin R. A., Belldegrun A. S. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Current Urology Reports. 2005;6(1):7–18. https://doi.org/10.1007/s11934–005–0062-xLam J. S., Leppert J. T., Figlin R. A., Belldegrun A. S. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Current Urology Reports. 2005;6(1):7–18. https://doi.org/10.1007/s11934–005–0062-xHuang W. C., Levey A. S., Serio A. M., Snyder M., Vickers A. J., Raj G. V., et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006 Sep;7(9):735–740. https://doi.org/10.1016/S1470–2045(06)70803–8Huang W. C., Levey A. S., Serio A. M., Snyder M., Vickers A. J., Raj G. V., et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006 Sep;7(9):735–740. https://doi.org/10.1016/S1470–2045(06)70803–8Ljungberg B., Bensalah K., Canfield S., Dabestani S., Hofmann F., Hora M., et al. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. European Urology. 2015;67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005Ljungberg B., Bensalah K., Canfield S., Dabestani S., Hofmann F., Hora M., et al. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. European Urology. 2015;67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005Kim S. P., Thompson R. H., Boorjian S. A., Weight C. J., Han L. C., Murad M. H., et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012 Jul;188(1):51–57. https://doi.org/10.1016/j.juro.2012.03.006Kim S. P., Thompson R. H., Boorjian S. A., Weight C. J., Han L. C., Murad M. H., et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012 Jul;188(1):51–57. https://doi.org/10.1016/j.juro.2012.03.006Smaldone M. C., Kutikov A., Egleston B., Simhan J., Canter D. J., Teper E., et al. Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology. 2012 Aug;80(2):286–291. https://doi.org/10.1016/j.urology.2012.02.067Smaldone M. C., Kutikov A., Egleston B., Simhan J., Canter D. J., Teper E., et al. Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology. 2012 Aug;80(2):286–291. https://doi.org/10.1016/j.urology.2012.02.067Andrews J. R., Atwell T., Schmit G., Lohse C. M., Kurup A. N., Weisbrod A., et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol. 2019 Aug;76(2):244–251. https://doi.org/10.1016/j.eururo.2019.04.026Andrews J. R., Atwell T., Schmit G., Lohse C. M., Kurup A. N., Weisbrod A., et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol. 2019 Aug;76(2):244–251. https://doi.org/10.1016/j.eururo.2019.04.026Kane C. J., Mallin K., Ritchey J., Cooperberg M. R., Carroll P. R. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul;113(1):78–83. https://doi.org/10.1002/cncr.23518Kane C. J., Mallin K., Ritchey J., Cooperberg M. R., Carroll P. R. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008 Jul;113(1):78–83. https://doi.org/10.1002/cncr.23518Shvero A., Nativ O., Abu-Ghanem Y., Zilberman D., Zaher B., Levitt M., et al. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer. Clin Genitourin Cancer. 2018;16(3): e613–e617. https://doi.org/10.1016/j.clgc.2017.10.016Shvero A., Nativ O., Abu-Ghanem Y., Zilberman D., Zaher B., Levitt M., et al. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer. Clin Genitourin Cancer. 2018;16(3): e613–e617. https://doi.org/10.1016/j.clgc.2017.10.016Lau W. K., Blute M. L., Weaver A. L., Torres V. E., Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000 Dec;75(12):1236–1242. https://doi.org/10.4065/75.12.1236Lau W. K., Blute M. L., Weaver A. L., Torres V. E., Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000 Dec;75(12):1236–1242. https://doi.org/10.4065/75.12.1236Van Poppel H., Da Pozzo L., Albrecht W., Matveev V., Bono A., Borkowski A., et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011 Apr;59(4):543–552. https://doi.org/10.1016/j.eururo.2010.12.013Van Poppel H., Da Pozzo L., Albrecht W., Matveev V., Bono A., Borkowski A., et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011 Apr;59(4):543–552. https://doi.org/10.1016/j.eururo.2010.12.013Bertolo R., Garisto J., Sagalovich D., Dagenais J., Agudelo J., Kaouk J. Achieving tumour control when suspecting sinus fat involvement during robot-assisted partial nephrectomy: step-by-step. BJU International. 2019;123(3):548–556. https://doi.org/10.1111/bju.14552Bertolo R., Garisto J., Sagalovich D., Dagenais J., Agudelo J., Kaouk J. Achieving tumour control when suspecting sinus fat involvement during robot-assisted partial nephrectomy: step-by-step. BJU International. 2019;123(3):548–556. https://doi.org/10.1111/bju.14552An J. Y., Ball M. W., Gorin M. A., Hong J. J., Johnson M. H., Pavlovich C. P., et al. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes. Urology. 2017 Feb;100:151–157. https://doi.org/10.1016/j.urology.2016.10.047An J. Y., Ball M. W., Gorin M. A., Hong J. J., Johnson M. H., Pavlovich C. P., et al. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes. Urology. 2017 Feb;100:151–157. https://doi.org/10.1016/j.urology.2016.10.047Mir M. C., Derweesh I., Porpiglia F., Zargar H., Mottrie A., Autorino R. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol. 2017;71(4):606–617. https://doi.org/10.1016/j.eururo.2017.06.005Mir M. C., Derweesh I., Porpiglia F., Zargar H., Mottrie A., Autorino R. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies. Eur Urol. 2017;71(4):606–617. https://doi.org/10.1016/j.eururo.2017.06.005

The authors declare that there are no conflicts of interest present.